Robert Floch
Vorstandsvorsitzender bei DrugAbuse Pharmaceutical, Inc.
Profil
Robert Floch is currently the Chief Executive Officer at DrugAbuse Pharmaceutical, Inc. He previously held positions as Director of Research & Development at Rhone Merieux, General Manager-European Operations at SangStat Medical Corp., Principal at Merial SAS, and Vice President-Clinical Development at Effimune SA. He obtained a doctorate degree from the University of Nantes.
Aktive Positionen von Robert Floch
Unternehmen | Position | Beginn |
---|---|---|
DrugAbuse Pharmaceutical, Inc.
DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Vorstandsvorsitzender | 01.10.2003 |
Ehemalige bekannte Positionen von Robert Floch
Unternehmen | Position | Ende |
---|---|---|
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Corporate Officer/Principal | - |
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Technik-/Wissenschafts-/F&E-Leiter | - |
Effimune SA
Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Technik-/Wissenschafts-/F&E-Leiter | - |
SangStat Medical Corp. | Corporate Officer/Principal | - |
Ausbildung von Robert Floch
University of Nantes | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
SangStat Medical Corp. | Health Technology |
DrugAbuse Pharmaceutical, Inc.
DrugAbuse Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology DrugAbuse Pharmaceuticals, Inc. develops medications for the treatment of alcohol and other drug addictions. The company is headquartered in Lexington, MA. | Health Technology |
Rhone Merieux
Rhone Merieux Chemicals: SpecialtyProcess Industries Part of Zoetis, Inc., Rhone Merieux manufactures pharmaceuticals, specialty, and agricultural chemicals. | Process Industries |
Merial SAS
Merial SAS Pharmaceuticals: MajorHealth Technology Merial SAS develops, manufactures, and distributes pharmaceutical products and vaccines for animals. It provides therapeutic medicines that treat the diseases of dogs, cats, chickens, cows, pigs, and horses. The company was founded in 1997 and is headquartered in Treillieres, France. | Health Technology |
Effimune SA
Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France. | Health Technology |